AAAAAA

   
Results: 1-11 |
Results: 11
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
Authors: Garcia, F Plana, M Ortiz, GM Bonhoeffer, S Soriano, A Vidal, C Cruceta, A Arnedo, M Gil, C Pantaleo, G Pumarola, T Gallart, T Nixon, DF Miro, JM Gatell, JM
Citation: F. Garcia et al., The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F29-F40
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/l
Authors: Garcia, F Plana, M Soriano, A Vidal, C Arnedo, M Gil, C Cruceta, A Pumarola, T Gallart, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/l, AIDS, 15(1), 2001, pp. 131-133
Thyroid autoimmune disease - Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers
Authors: Armengol, MP Juan, M Lucas-Martin, A Fernandez-Figueras, MT Jaraquemada, D Gallart, T Pujol-Borrell, R
Citation: Mp. Armengol et al., Thyroid autoimmune disease - Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers, AM J PATH, 159(3), 2001, pp. 861-873
Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states ofHIV disease
Authors: Tortajada, C Garcia, F Plana, T Gallart, T Maleno, MJ Miro, JM Gatell, JM
Citation: C. Tortajada et al., Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states ofHIV disease, J ACQ IMM D, 25(4), 2000, pp. 296-305
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study
Authors: Garcia, F Alonso, MM Romeu, J Knobel, H Arrizabalaga, J Ferrer, E Dalmau, D Ruiz, I Vidal, F Frances, A Segura, F Gomez-Sirvent, JL Cruceta, A Clotet, B Pumarola, T Gallart, T O'Brien, WA Miro, JM Gatell, JM
Citation: F. Garcia et al., Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study, J ACQ IMM D, 25(1), 2000, pp. 26-35
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study
Authors: Garcia, F Knobel, H Sambeat, MA Arrizabalaga, J Aranda, M Romeu, J Dalmau, D Segura, F Gomez-Sirvent, JL Ferrer, E Cruceta, A Gallart, T Pumarola, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study, AIDS, 14(16), 2000, pp. 2485-2494
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
Authors: Plana, M Garcia, F Gallart, T Tortajada, C Soriano, A Palou, E Maleno, MJ Barcelo, JJ Vidal, C Cruceta, A Miro, JM Gatell, JM
Citation: M. Plana et al., Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection, AIDS, 14(13), 2000, pp. 1921-1933
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study
Authors: Garcia, F Romeu, J Grau, I Sambeat, MA Dalmau, D Knobel, H Gomez-Sirvent, JL Arrizabalaga, J Cruceta, A Clotet, B Podzamczer, D Pumarola, T Gallart, T O'Brien, WA Miro, JM Gatell, JM
Citation: F. Garcia et al., A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study, AIDS, 13(17), 1999, pp. 2377-2388
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication
Authors: Garcia, F Niebla, G Romeu, J Vidal, C Plana, M Ortega, M Ruiz, L Gallart, T Clotet, B Miro, JM Pumarola, T Gatell, JM
Citation: F. Garcia et al., Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication, AIDS, 13(12), 1999, pp. 1491-1496
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
Authors: Garcia, F Plana, M Vidal, C Cruceta, A O'Brien, WA Pantaleo, G Pumarola, T Gallart, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy, AIDS, 13(11), 1999, pp. F79-F86
Identification of a natural soluble form of human CD5
Authors: Calvo, J Places, L Espinosa, G Padilla, O Vila, JM Villamor, N Ingelmo, M Gallart, T Vives, J Font, J Lozano, F
Citation: J. Calvo et al., Identification of a natural soluble form of human CD5, TISSUE ANTI, 54(2), 1999, pp. 128-137
Risultati: 1-11 |